首页>
外国专利>
polypeptides, ecd fgfr4 fusion molecules, pharmaceutical compositions, polynucleotide and methods of treating angiogenic disorder, patient cancer and patient macular degeneration and their uses
polypeptides, ecd fgfr4 fusion molecules, pharmaceutical compositions, polynucleotide and methods of treating angiogenic disorder, patient cancer and patient macular degeneration and their uses
Fibroblast growth factor receptor (FGFR) extracellular domain (ECD) acidic region muteins that have been engineered to exhibit decreased tissue binding by increasing the number of acidic amino acid residues within the D1-D2 linker region are provided. Polynucleotides encoding FGFR ECD acidic region muteins are also provided. Methods of making FGFR ECD acidic region muteins, and methods of using such molecules to treat proliferative disorders, including cancers, disorders of angiogenesis, and macular degeneration, are also provided.
展开▼